While the MFDA has put out this warning, it is also worth noting that Iko Biologicals, the company producing this medication is not on the list of authorised suppliers for importing and selling drugs in the Maldives.
SunOnline International
The Maldives Food and Drug Authority (MFDA) has put out another cautionary warning against a medication due to quality issues. In an announcement, the MFDA stated that there are quality issues with ‘Normal Immunoglobulin for IV’, which is a medication manufactured in India.
These concerns were initially raised by the World Health Organisation (WHO), which reported a quality concern which was detected in certain batches of the drug. This is not the first time that the MFDA has warned the public of medication that does not meet the needed quality. The latest medication is noted to be produced by the Indian Pharmaceutical company Iko Biologicals.
While the MFDA has put out this warning, it is also worth noting that Iko Biologicals, the company producing this medication is not on the list of authorised suppliers for importing and selling drugs in the Maldives. With this, the public can be assured that this medication will not be available in the Maldives, however, the warnings have been put out as Maldivians often travel to countries like India and Sri Lanka for medical treatment and may need to be made aware of these quality issues. MFDA has noted that no batches of the medication have been imported into the Maldives by the prescribed regulations.
Earlier this month, MFDA had also issued warnings about 16 different medications which were suspected to have potential quality issues. While none of the medications were imported into the Maldives through any official channels, similar warnings were put out so the public could remain cautious when travelling for medical reasons.
